A French study found professional goat exposure increases risk of pneumonic-type lung adenocarcinoma (P-ADC) fivefold compared to other lung cancers. P-ADC is more common in females and those with no smoking history.
A major UK trial found that giving radiotherapy between or during chemotherapy cycles significantly reduces the risk of breast cancer recurring in the breast or chest wall. The treatment, known as synchronous chemoradiation, has minimal adverse side-effects and no detrimental effect on quality of life.
A Phase II study showed that trastuzumab emtansine (T-DM1) significantly delayed breast cancer progression, improving patients' lives with fewer side effects. The treatment improved time to disease worsening by 41% compared to standard docetaxel chemotherapy plus trastuzumab.
Scientists have found a new family of wasps in North American amber, which are closely related to families found in South America and southern Africa. The discovery sheds light on the origins of stinging wasps and their distribution patterns.
Researchers have developed a new bone-targeting drug that can delay the onset of metastases in hormone-resistant prostate cancer patients. The study showed that denosumab prolonged bone metastasis-free survival significantly compared to placebo, improving patient quality of life.
A study comparing 6,597 patients across four European countries found substantial differences in treatment approaches for rectal cancer. The use of radiotherapy and chemotherapy varied greatly between countries, despite comparable stages of disease.
The study found that 80% of participants reported inability to maintain their pre-COPD lifestyle, while 1 in 4 struggled to care for their children or family members. The research highlights the significant psychosocial and financial impact of COPD on working-age individuals, particularly in achieving life goals.